Figure 5.
Cumulative incidence of ostomy creation in patients without anorectal stricture. The cumulative incidence of ostomy creation was 25.0%/5 years with infliximab (IFX) (n = 7) and 18.5%/5 years without IFX (n = 15), respectively.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.